827579-70-4

Basic information

• Product Name: N-[1-(4-fluoro-phenyl)-ethyl]-5-(methanesulfonyl-methyl-amino)-isophthalamic acid methyl ester
• Synonyms: N-[1-(4-fluoro-phenyl)-ethyl]-5-(methanesulfonyl-methyl-amino)-isophthalamic acid methyl ester
• CAS NO: 827579-70-4
• Molecular Weight: 408.451
• Mol File: 827579-70-4.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: N-[1-(4-fluoro-phenyl)-ethyl]-5-(methanesulfonyl-methyl-amino)-isophthalamic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: N-[1-(4-fluoro-phenyl)-ethyl]-5-(methanesulfonyl-methyl-amino)-isophthalamic acid methyl ester(827579-70-4)
• EPA Substance Registry System: N-[1-(4-fluoro-phenyl)-ethyl]-5-(methanesulfonyl-methyl-amino)-isophthalamic acid methyl ester(827579-70-4)

Safety Data

• Hazardous Substances Data: 827579-70-4(Hazardous Substances Data)

Upstream product

• 62814-45-3 5-methanesulphonylamino-isophthalic acid dimethyl ester 
• 695215-93-1 dimethyl-5-[methyl(methylsulfonyl)amino]isophthalate 
• 99-27-4 dimethyl 5-aminoisophthalate 
• 374898-01-8 (R)-1-(4-fluorophenyl)ethylamine 
• 695215-94-2 3-(methoxycarbonyl)-5-[methyl(methylsulfonyl)amino]benzoic acid 

Downstream Products

• 868286-91-3 C₃₃H₃₈FN₅O₆S 
• 695216-22-9 N-(1-benzyl-3-cyclopropylamino-2-hydroxy-propyl)-N'-[1-(4-fluoro-phenyl)-ethyl]-5-(methanesulfonyl-methyl-amino)-isophthalamide 
• 868286-83-3 (1-{5-[3-[1-(4-fluoro-phenyl)-ethylcarbamoyl]-5-(methanesulfonyl-methyl-amino)-phenyl]-[1,3,4]oxadiazol-2-yl}-1-methyl-2-phenyl-ethyl)-carbamic acid tert-butyl ester 
• 928330-65-8 2-tert-butoxycarbonylamino-2-methyl-3-phenyl-propionic acid 3-[1-(4-fluoro-phenyl)-ethylcarbamoyl]-5-(methanesulfonyl-methyl-amino)-benzyl ester 
• 928330-28-3 2-[3-[1-(4-fluoro-phenyl)-ethylcarbamoyl]-5-(methanesulfonyl-methyl-amino)-benzoylamino]-2-hydroxymethyl-3-phenyl-propionic acid methyl ester 
• 827039-72-5 N-(1,1-bis-hydroxymethyl-2-phenyl-ethyl)-N'-[1-(4-fluoro-phenyl)-ethyl]-5-(methanesulfonyl-methyl-amino)-isophthalamide 
• 928330-35-2 4-benzyl-2-[3-[1-(4-fluoro-phenyl)-ethylcarbamoyl]-5-(methanesulfonyl-methyl-amino)-phenyl]-4,5-dihydro-oxazole-4-carboxylic acid methyl ester 
• 928330-08-9 N'-[3-[1-(4-fluoro-phenyl)-ethylcarbamoyl]-5-(methanesulfonyl-methyl-amino)-benzoyl]-hydrazinecarboxylic acid tert-butyl ester 
• 918344-80-6 N-[(1R)-1-(4-fluorophenyl)ethyl]-3-(hydrazinocarbonyl)-5-[methyl(methylsulfonyl)amino]benzamide 
• 849622-95-3 3-(bromomethyl)-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide 
• 928330-07-8 N-[1-(4-fluoro-phenyl)-ethyl]-3-hydroxymethyl-5-(methanesulfonyl-methyl-amino)-benzamide 
• 695215-96-4 3-({[(1R)-1-(4-fluorophenyl)ethyl]amino}carbonyl)-5-[methyl(methylsulfonyl)amino]benzoic acid 

Relevant articles and documents

COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1-R13, A, B, L and i are as defined in the description and the claims. The invention also relates to the use thereof for treating Alzheimer's disease (AD) and similar diseases.

Discovery of oxadiazoyl tertiary carbinamine inhibitors of β-secretase (BACE-1)

We describe the discovery and optimization of tertiary carbinamine derived inhibitors of the enzyme β-secretase (BACE-1). These novel non-transition-state-derived ligands incorporate a single primary amine to interact with the catalytic aspartates of the

1,3,5-SUBSTITUTED PHENYL DERIVATIVE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

The present invention is directed to 1,3,5-phenyl substituted derivative compounds which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.